Insmed’s drug Brinsupri (brensocatib) has landed a double regulatory landmark win, becoming both the first marketed dipeptidyl peptidase 1 (DPP1) inhibitor and the first therapy for non-cystic ...

PureTech's latest spinoff Celea Therapeutics was created to progress the former's lead respiratory IPF programme, ...

SetPoint Medical has secured $140m in private financing to accelerate the commercialisation of its SetPoint System, a ...

As cyber attacks on major retailers like Pandora continue to hit headlines, experts are urging ecommerce businesses to step ...

Our editorial team dives into the pharma industry's reaction to US tariffs on imports from the European Union and major ...

Survey suggests power infrastructure is the biggest barrier to investing in battery-electric vehicles (BEVs) in mining.

"Third time lucky as PharmaTher gets FDA approval for ketamine" was originally created and published by Pharmaceutical ...

The breach was one of the largest reported cyberattack in insurance, as Allianz Life has around 1.4 million customers in the ...

South Korea is fast becoming a focal point for global biopharmaceutical licensing, with deal values reaching $7.86 billion ...

Novartis' mAb ianalumab helped maintain safe platelet levels for a prolonged period, reducing patient reliance on hospital ...

Greater China emerges as key player, driven by Hong Kong’s resurgence and "shifting global capital flows toward Chinese ...